RxDoctor Payments Data

John Moore, DPM

Foot & Ankle Surgery · Asheville, NCNPI 1790852895

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.7% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Smith+Nephew at 31.7% of the total. Reporting peaked in 2023 at $505 and has fallen 67.6% since, to $163 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in NC, where the typical reported total is $2,671.

$1,666in general payments, 2019–2025

Across 62 payments — averaging $26.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$528
  • Acera Surgical, Inc.$213
  • Averitas Pharma Inc.$161
  • Nevro Corp.$110
  • Amniox Medical, Inc.$100
  • Next Science LLC$97
  • plus $456 from 19 others
$12,500in ownership & investment interests, 2019–2025

Across 6 payments — averaging $2083.33 each. An ownership or investment interest held by the physician or an immediate family member.

  • Gramercy Extremity Orthopedics LLC$13K

What the payments were for

  • Food & beverage$1,64499%
  • Entertainment$221%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,666 in reported general payments places this provider in the 35th percentile of 196 foot & ankle surgery providers in North Carolina.

See all foot & ankle surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$83,505
Medicare patients
152
Services billed
8,497

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl15$67

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Asheville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →